Re-Imagining A Sustainable Pharma: ISPE Singapore affiliate annual meeting

Update : 24th June, 2024

ISPE Singapore Conference & Exhibition

28-30 Aug 2024 | Suntec Singapore

With increasing awareness of the environmental and social impact of pharmaceutical production and distribution, the pharmaceutical and bio manufacturing industry is striving to reduce its carbon footprint, minimize waste, and ensure ethical and responsible practices throughout the product lifecycle.

Across organisations and facilities, how are we employing sustainable processes, adopting enabling technologies, and embracing innovation? All while optimising efficiencies, productivity, and maintaining the highest standards of product quality and safety.

Organised and developed by its professional member volunteers, ISPE Singapore’s annual conference & exhibition highlights global and local best practices in process technology and innovations.

This year’s theme will examine the progress and challenges involved alongside key trends impacting the sector. International and Asian manufacturers, regulatory agencies, and subject matter experts will share case studies and latest knowledge from manufacturing facility design to finished product.

REGISTER NOW!

Early Bird: Register on or before 30 June and save SGD200!

Programme Preview

Manufacturers: Pfizer, Roche, Novartis, Sanofi, MSD, Jiangsu Hillgene Biopharma, Takeda, Lonza, Amgen, Genentech, WuXi Biologics, Genepeutic Bio, Merck, GenScript, and GSK

Regulatory Agencies: WHO, PIC/s, HSA, PMDA, TGA

Key issues faced by the industry:

PLENARY

  • Re-Imagining a Sustainable Pharma: Harmonisation, Reliance, Convergence
  • Regulatory: International Harmonization and Reliance

DIGITAL TRANSFORMATION / PHARMA 4.0

  • Unlocking Value with GenAI: Case Studies in Pharma
  • How Can Automation Help to Achieve Sustainability Goals?
  • AI & Digital CQV

SUSTAINABLE MANUFACTURING

  • Sustainability Initiatives in BioPharma Manufacturing
  • Can the Biomanufacturing Industry Reach Net Zero Carbon Emissions?

CMC & QUALITY

  • Navigating CMCs for ATMPs
  • Global Implementation of Post-Approval Changes: How Differences in Global Requirements Can Lead to Drug Shortages

ATMPs MANUFACTURING

  • Strategies for CAR T Manufacture Process and Analytical Method Development
  • Challenges for CGT Organizations in APAC
  • Expediting Affordable Advanced Therapies for Patients in Asia

Over 80 industry speakers include 30+ regulatory agencies & bio / pharma manufacturers

2024 Speaker Faculty including:

  • Dr Clive Tan, Assistant Chief Group Integrated Care (Population Health), National Healthcare Group Singapore
  • Alfonsus Karli, President ISPE Singapore Affiliate & Director GCMC Vaccines, Pfizer Singapore
  • Dr Georg Singewald, International Board of Directors ISPE, Global Head of Engineering Technology & Sustainability, Roche Switzerland
  • Jessica Hale, Global Regulatory Affairs & Clinical Safety, Merck USA
  • Dr Joey Gouws, PQT Inspections Lead, World Health Organization (retired), S. Africa
  • Dr Kentaro Hara, Division Director, Division of Inspection for Drugs I, Office of Manufacturing Quality for Drugs, PMDA Japan
  • Chong Hock Sia, Director (Quality Assurance) & Senior Consultant (Audit & Licensing), Health Products Regulation Group, Health Sciences Authority Singapore
  • Jennifer Burnett, Assistant Secretary, Manufacturing Quality, TGA Australia
  • Rajnish Narula, Director, Business Excellence, Pfizer Singapore
  • Steven Yu, Digital Area Manager Asia, Sanofi Vaccine Manufacturing & Supply, Singapore
  • Wilbur Ho, Senior Director, Digital Manufacturing Operations Asia Pacific, MSD Singapore
  • Dr Yuan Zhao, CTO, Jiangsu Hillgene Biopharma, China
  • Ngee Ping Ng, Head of Facilities and Engineering, Roche Singapore Technical Operations, Singapore
  • George Lam, Site Head, Takeda Singapore

Biggest gathering for Bio/Pharma manufacturers in Singapore

The Singapore affiliate collaborates with its regional affiliates including Indonesia, Malaysia, Philippines, and Thailand to support delegations to the event. Outreach extends through its co-operation with the Vietnam Pharmaceutical Companies Association (VNPCA) to enable leading companies to attend.

Snapshot from 2023:

 

This year’s annual gathering aims to surpass its biggest event in 2023. The exhibition was sold-out last year and has been expanded to accommodate 30% more space and more than 100 exhibiting companies.

New! 2 Open Tracks Concurrent with Main Conference

Alongside the main conference which is also livestreamed, 2 Open Tracks with workshops will run concurrently and are free to attend. This year’s programme will highlight 4 ‘Lunch ‘n Learn’ workshops hosted by Ecolab, Exyte, Ingersoll Rand, and Siemens. Additional focus sessions will complement the conference with extended discussions and case studies.

New! ISPE Communities of Practice (CoPs)

ISPE member volunteers are encouraged to join their peers in regional and global ‘Communities of Practice’ (CoP) meetings. Along with Special Interest Groups, Contributors and sub-committees have developed best practice guides and training across multiple core areas. This year’s conference will bring members and speakers together culminating in a combined lunch in these areas:

  • GAMP/Pharma 4.0
  • CQV
  • CU
  • Regulatory Quality Harmonization Committee (RQHC)

Also hosted onsite, a daily ‘Power Hour’ programme of 15 minute demonstrations / talks will take place at participating exhibitors’ stands. The full schedule comprising Conference Open Tracks and Power Hour can be viewed on the event website: www.ispesingapore.org

ISPE Singapore’s Student & Emerging Leaders Chapters will host its popular annual Hackathon where the final judging will take place onsite. A truly collaborative challenge, competing teams are comprised of students and young professionals from the region.

ISPE’s Women in Pharma committee welcomes all to its Roundtable Lunch featuring topical career related discussions each hosted by an inspirational leader.

Rounding off each day, informal networking opportunities abound with the Pharmanite Reception held in the exhibit hall and Emerging Leaders Networking after the event ends a short walk from the venue.

Pre-Event Workshop, Site Tour & ISPE Training

Additional learning can be found in the pre-event programme:

  • Designing an Effective Contamination Control Strategy (Cleaning and Disinfection) in Compliance to Annex 1: Free workshop sponsored by STERIS Corporation
  • ISPE GAMP® Basic Principles Training: Basic Principles of Computerized Systems Compliance: Applying the GAMP® 5 Guide: A Risk-based Approach to Compliant GxP Computerized Systems Second Edition (T07)
  • Site Tour to Rockwell Automation's Singapore Customer Experience Center

Remaining exhibit stands from Table Top displays are available for product and service providers. Tailored sponsorship options provide pre-event and onsite branding. View the latest floorplan and packages here and 2024 Sponsors & Exhibitors here.

Reviews…

‘An awesome time at the ISPE Singapore Affiliate event…’ ‘It was a pleasure to be part of such a great event for ISPE in the APAC region and to build the Sygna network across the Life Science / Pharma industry…’ [K Hughes Sygna]

‘This year’s event was bigger than the previous few years. Not to mention the number of visitors as well’ [Terry K-Capital]

‘Our participation at ISPE Singapore Affiliate Conference 2023 was a success as we connected with professionals from the pharmaceutical and biomedical sectors. Our Workshop drew a packed crowd fostering insightful discussions with our experts…’ [A Ang Exyte]

‘It was an absolute pleasure to be sharing the stage with….this morning in the Visionary Panel: Biotechnology Industry Challenges ….’ [CM Chai Lonza]

About ISPE

The International Society for Pharmaceutical Engineering is the world’s largest not-for-profit association serving its Members by leading scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. ISPE Singapore Affiliate has over 300 active members with 5000 supporters predominantly in Singapore and the region.

Source : ISPE


This news article complies with our Editorial Policy

Other News

Follow Us